Patrick Raber

1.5k total citations
15 papers, 1.2k citations indexed

About

Patrick Raber is a scholar working on Immunology, Biotechnology and Oncology. According to data from OpenAlex, Patrick Raber has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Biotechnology and 4 papers in Oncology. Recurrent topics in Patrick Raber's work include Immune cells in cancer (7 papers), Cancer Research and Treatments (6 papers) and Immune Cell Function and Interaction (5 papers). Patrick Raber is often cited by papers focused on Immune cells in cancer (7 papers), Cancer Research and Treatments (6 papers) and Immune Cell Function and Interaction (5 papers). Patrick Raber collaborates with scholars based in United States, South Africa and Japan. Patrick Raber's co-authors include Paulo C. Rodrı́guez, Augusto C. Ochoa, Rosa A. Sierra, Paul Thevenot, Dorota Wyczechowska, María E. Ramírez, Amir A. Al-Khami, Matthew Fletcher, Luis Del Valle and Jimena Trillo-Tinoco and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Patrick Raber

14 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Raber United States 10 767 403 315 189 108 15 1.2k
Claudia Patricia Pardo Hernández United States 8 648 0.8× 248 0.6× 230 0.7× 117 0.6× 68 0.6× 12 996
Ryan Sowell United States 9 979 1.3× 394 1.0× 507 1.6× 194 1.0× 119 1.1× 14 1.4k
Kai‐Li He China 9 629 0.8× 179 0.4× 448 1.4× 258 1.4× 67 0.6× 11 1.1k
Yaoyao Shi China 12 434 0.6× 392 1.0× 489 1.6× 135 0.7× 61 0.6× 18 980
Franz Kratochvill Austria 10 762 1.0× 339 0.8× 646 2.1× 250 1.3× 66 0.6× 11 1.3k
Yu‐Shan Wang Taiwan 17 275 0.4× 245 0.6× 253 0.8× 100 0.5× 49 0.5× 46 773
Kevin A. Myers United Kingdom 17 335 0.4× 357 0.9× 460 1.5× 162 0.9× 66 0.6× 28 925
Daniela Giunciuglio Italy 15 226 0.3× 261 0.6× 500 1.6× 216 1.1× 130 1.2× 18 1.0k
Reza Mirzaei Iran 15 366 0.5× 251 0.6× 259 0.8× 121 0.6× 45 0.4× 37 774
Sophia Djebali France 14 657 0.9× 267 0.7× 336 1.1× 81 0.4× 119 1.1× 21 1.1k

Countries citing papers authored by Patrick Raber

Since Specialization
Citations

This map shows the geographic impact of Patrick Raber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Raber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Raber more than expected).

Fields of papers citing papers by Patrick Raber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Raber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Raber. The network helps show where Patrick Raber may publish in the future.

Co-authorship network of co-authors of Patrick Raber

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Raber. A scholar is included among the top collaborators of Patrick Raber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Raber. Patrick Raber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Meskini, Rajaâ El, Nathan Pate, Michael D. Oberst, et al.. (2021). Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model. Molecular Cancer Research. 19(8). 1422–1436. 3 indexed citations
2.
Enninga, Elizabeth Ann L., Patrick Raber, Reade A. Quinton, et al.. (2020). Maternal T Cells in the Human Placental Villi Support an Allograft Response during Noninfectious Villitis. The Journal of Immunology. 204(11). 2931–2939. 27 indexed citations
3.
Mahalingam, Devalingam, Grey Wilkinson, Kevin H. Eng, et al.. (2019). Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study. Clinical Cancer Research. 26(1). 71–81. 142 indexed citations
4.
Fountzilas, Christos, Grey Wilkinson, Kevin H. Eng, et al.. (2019). Prediction of response to pelareorep plus pembrolizumab in pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 37(15_suppl). e15726–e15726. 2 indexed citations
5.
Raber, Patrick, Rosa A. Sierra, Paul Thevenot, et al.. (2016). T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy. Oncotarget. 7(14). 17565–17578. 14 indexed citations
6.
Fletcher, Matthew, María E. Ramírez, Rosa A. Sierra, et al.. (2014). l -Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells. Cancer Research. 75(2). 275–283. 219 indexed citations
7.
Sierra, Rosa A., Paul Thevenot, Patrick Raber, et al.. (2014). Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer. Cancer Immunology Research. 2(8). 800–811. 66 indexed citations
8.
Thevenot, Paul, Rosa A. Sierra, Patrick Raber, et al.. (2014). The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors. Immunity. 41(3). 389–401. 198 indexed citations
9.
Raber, Patrick, Paul Thevenot, Rosa A. Sierra, et al.. (2013). Subpopulations of myeloid‐derived suppressor cells impair T cell responses through independent nitric oxide‐related pathways. International Journal of Cancer. 134(12). 2853–2864. 243 indexed citations
10.
Ramírez, María E., et al.. (2013). Modulation Of T Cell Function Through L-Arginine Metabolism: A New Therapy From An Old Enemy. Blood. 122(21). 1039–1039.
11.
Ramírez, María E., et al.. (2013). Modulation of T cell function through L-arginine metabolism: a new therapy from an old enemy. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). O10–O10. 1 indexed citations
12.
Raber, Patrick, Augusto C. Ochoa, & Paulo C. Rodrı́guez. (2012). Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives. Immunological Investigations. 41(6-7). 614–634. 231 indexed citations
13.
Morrow, Kevin, Claudia Patricia Pardo Hernández, Patrick Raber, et al.. (2012). Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia. Leukemia. 27(3). 569–577. 43 indexed citations
14.
Raber, Patrick, Dorota Wyczechowska, & Paulo C. Rodrı́guez. (2012). Granulocytic and monocytic populations of tumor-infiltrating myeloid-derived suppressor cells (MDSC) suppress T cell proliferation through independent mechanisms (74.7). The Journal of Immunology. 188(1_Supplement). 74.7–74.7. 2 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026